首页 | 本学科首页   官方微博 | 高级检索  
     

姜黄素对二乙胺基亚硝胺诱发小鼠肝癌前病变的预防作用
引用本文:焦艺博,刘晓婷,毛文超,张健,冯丽莉,田民强,张东星,蔡大勇,王玥琦. 姜黄素对二乙胺基亚硝胺诱发小鼠肝癌前病变的预防作用[J]. 中国药师, 2012, 15(9): 1218-1222
作者姓名:焦艺博  刘晓婷  毛文超  张健  冯丽莉  田民强  张东星  蔡大勇  王玥琦
作者单位:1. 北京中医药大学,北京,100029;天津医科大学总医院药剂科
2. 北京中医药大学,北京,100029
3. 中国医学科学院药用植物研究所
基金项目:国家“重大新药创制”科技重大专项(编号:2009ZX09502-017); 教育部重点研究资助项目(编号:108019); 北京中医药大学创新团队项目(编号:2011-CXD-04)
摘    要:目的:观察姜黄素对小鼠肝癌前病变的预防作用.方法:每周腹腔注射二乙基亚硝胺(DEN,95 mg·kg-1)建立小鼠肝癌前病变,每天灌胃姜黄素(120 mg·kg-1)或姜黄素与山药(3.03 g·kg-1)联合用药,连续10周(70 d);第71天眼球后静脉丛取血,检测血清肝功指标丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)和谷胱甘肽-S-转移酶(GST),肝脏经灌注固定后用光学显微镜观察病理组织学变化.结果:模型组小鼠肝脏同时存在变质与修复性病变,增生肝细胞具有异型性;血清ALT:(195.57±91.56) U·L-1、AST:(39.68±24.20) U·L-1、GST:(42.31±8.19)U·L-1升高明显(P<0.01).姜黄素组肝损伤较轻,增生肝细胞异型性降低,ALT:(98.54±48.07) U·L-1、AST:(26.89±7.51) U·L-1、GST:(47.47±8.54) U·L-1下降明显(P<0.05),姜黄素联合山药组ALT:(82.75±38.54) U·L-1、AST:(30.32±7.80) U·L-1、GST:(24.61±7.58) U·L-1疗效优于单用(P<0.01).结论:姜黄素对诱导性小鼠肝癌前病变具有防治作用,姜黄素与山药联合用疗效更佳.

关 键 词:姜黄素  小鼠肝癌前病变  二乙基亚硝胺  预防  山药水提物
收稿时间:2012-05-10
修稿时间:2012-06-18

Preventive Effect of Curcumin on DEN-induced Hepatic Precancerous Lesions in Mice
Jiao Yibo,Liu Xiaoting,Mao Wenchao,Zhang Jian,Feng Lili,Tian Minqiang,Zhang Dongxing,Cai Dayong and Wang Yueqi. Preventive Effect of Curcumin on DEN-induced Hepatic Precancerous Lesions in Mice[J]. China Pharmacist, 2012, 15(9): 1218-1222
Authors:Jiao Yibo  Liu Xiaoting  Mao Wenchao  Zhang Jian  Feng Lili  Tian Minqiang  Zhang Dongxing  Cai Dayong  Wang Yueqi
Affiliation:Jiao Yibo,Liu Xiaoting,Mao Wenchao,Zhang Jian,Feng Lili,Tian Minqiang,Zhang Dongxing,Cai Dayong,Wang Yueqi(1.Beijing University of Chinese Medicine,Beijing 100029,China;2.Department of Pharmacy,General Hospital of Tianjin Medical University;3.The Institute of Medicinal Plant Development)
Abstract:Objective: To confirm the protective effect of curcumin on diethylnitrosamine(DEN)-induced hepatic precancerous lesions in mice.Method: The male mice were randomly divided into four groups.The hepatic precancerous lesions in mice were replicated with DEN(95 mg·kg-1) intraperitoneal administration once a week for 10 weeks,meanwhile curcumin(120.0 mg·kg-1) with or without Rhizoma Dioscoreae(3.03 g·kg-1) was administrated intragastrically once a day to protect the hepatic precancerous lesions.On the 71st day,the blood was collected to detect the hepatic injury biomarkers,and partial liver was fixed to observe the pathological changes.Result: Compared with those in the control mice,the hepatic precancerous lesions in the model mice were confirmed as the alterative and proliferative changes of liver,the proliferative hepatocytes were demonstrated as the atypia similar to hepatic carcinoma,the alterative changes were supported by the elevated activities of serum ALT(195.57±91.56) U·L-1,AST(39.68±24.20) U·L-1 and GST(42.31±8.19)U·L-1.The administration of curcumin relieved the hepatic precancerous lesions significantly(P0.01),and the combination use of curcumin and Rhizoma Dioscoreae could enhance the effect(P0.05) in the treatment groups with ALT(82.75±38.54) U·L-1,AST(30.32±7.80) U·L-1and GST(24.61±7.58) U·L-1,respectively.Conclusion: Curcumin can protect the hepatic precancerous lesions in the mice attacked by diethylnitrosamine,and combination use of curcumin and Rhizoma Dioscoreae can be more effective.
Keywords:Curcumin  Hepatic precancerous lesions  Diethylnitrosamine  Mouse
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国药师》浏览原始摘要信息
点击此处可从《中国药师》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号